Stenocare A/S (CPH:STENO)
1.395
+0.070 (5.28%)
Feb 6, 2026, 11:48 AM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 57.23 million as of February 6, 2026. Its market cap has increased by 258.08% in one year.
Market Cap
57.23M
Enterprise Value
55.14M
Revenue
5.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.40
Market Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 57.23M, a decrease of -82.49%. That is a compound annual growth rate of -26.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 62.42M | -2.36% |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.63T |
| Genmab | 129.17B |
| Coloplast | 117.87B |
| ALK-Abelló | 48.66B |
| BioPorto | 486.68M |
| Pharma Equity Group | 131.35M |
| ViroGates | 120.66M |
| Scandinavian Medical Solutions | 109.83M |